Android Apple

Here's What Analysts Are Forecasting For Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) After Its Third-Quarter Results

By Yahoo! Finance   |   1 month ago
Here's What Analysts Are Forecasting For Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) After Its Third-Quarter Results

Intra-Cellular Therapies' shares surged 14% after its latest quarterly results, with analysts forecasting a 52% revenue increase by 2025. Earnings per share are expected to rise, indicating a bullish outlook.

Read More

Did you find this insightful?

close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.